Correlation Between Cullinan Oncology and NuCana PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and NuCana PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and NuCana PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and NuCana PLC, you can compare the effects of market volatilities on Cullinan Oncology and NuCana PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of NuCana PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and NuCana PLC.

Diversification Opportunities for Cullinan Oncology and NuCana PLC

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cullinan and NuCana is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and NuCana PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuCana PLC and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with NuCana PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuCana PLC has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and NuCana PLC go up and down completely randomly.

Pair Corralation between Cullinan Oncology and NuCana PLC

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the NuCana PLC. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 2.18 times less risky than NuCana PLC. The stock trades about -0.21 of its potential returns per unit of risk. The NuCana PLC is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  141.00  in NuCana PLC on December 29, 2024 and sell it today you would lose (13.00) from holding NuCana PLC or give up 9.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  NuCana PLC

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
NuCana PLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NuCana PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NuCana PLC is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cullinan Oncology and NuCana PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and NuCana PLC

The main advantage of trading using opposite Cullinan Oncology and NuCana PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, NuCana PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuCana PLC will offset losses from the drop in NuCana PLC's long position.
The idea behind Cullinan Oncology LLC and NuCana PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA